Yoon Won Jae, Lee Jun Kyu, Lee Kwang Hyuck, Lee Woo Jin, Ryu Ji Kon, Kim Yong-Tae, Yoon Yong Bum
Department of Internal Medicine, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul 110-744, Korea.
Gastrointest Endosc. 2006 Jun;63(7):996-1000. doi: 10.1016/j.gie.2005.11.054.
The efficacy and complications of covered self-expandable metal stents (SEMS) remain controversial.
We conducted this study to compare the efficacies and complication rates of covered and uncovered SEMS in malignant biliary obstruction.
Data on patients who underwent endoscopic retrograde biliary drainage with covered or uncovered Wallstents for the palliation of unresectable distal malignant biliary obstruction were collected. Stent patency, complications, and causes of stent occlusion were analyzed.
We collected the data retrospectively.
A total of 77 patients received Wallstents for unresectable distal malignant biliary obstruction.
Endoscopic sphincterotomy was performed, and a Wallstent was deployed after guidewire passage. Polyurethane-covered Wallstents were used in 36 patients and uncovered Wallstents in 41 patients.
Stent migration occurred in 3 of the covered Wallstent group and in 1 of the uncovered Wallstent group. Cholecystitis occurred in 1 of the covered Wallstent group but in none of the uncovered Wallstent group. Stent occlusion occurred after a mean of 398 days in the covered group and after 319 days in the uncovered Wallstent group (P > .05). Stent patency rates were 83%, 78%, 67%, and 54% at 100, 200, 300, and 400 days, respectively, in covered group and 83%, 66%, 54%, and 36% in the uncovered group, which was not significantly different.
This study is not a prospective randomized study and sample size is not large.
Covered Wallstents are safe with acceptable complication rates. However, we found no significant difference between the stent patencies of covered and uncovered Wallstents.
覆膜自膨式金属支架(SEMS)的疗效及并发症仍存在争议。
本研究旨在比较覆膜与非覆膜SEMS在恶性胆管梗阻中的疗效及并发症发生率。
收集接受内镜逆行胆管引流术,使用覆膜或非覆膜Wallstent支架缓解不可切除的远端恶性胆管梗阻患者的数据。分析支架通畅情况、并发症及支架闭塞原因。
本研究为回顾性收集数据。
共有77例患者因不可切除的远端恶性胆管梗阻接受了Wallstent支架治疗。
行内镜括约肌切开术,导丝通过后植入Wallstent支架。36例患者使用聚氨酯覆膜Wallstent支架,41例患者使用非覆膜Wallstent支架。
覆膜Wallstent支架组有3例发生支架移位,非覆膜Wallstent支架组有1例发生支架移位。覆膜Wallstent支架组有1例发生胆囊炎,非覆膜Wallstent支架组无胆囊炎发生。覆膜组平均398天后发生支架闭塞,非覆膜组平均319天后发生支架闭塞(P>.05)。覆膜组在100、200、300和400天时的支架通畅率分别为83%、78%、67%和54%,非覆膜组分别为83%、66%、54%和36%,差异无统计学意义。
本研究并非前瞻性随机研究,样本量不大。
覆膜Wallstent支架安全,并发症发生率可接受。然而,我们发现覆膜与非覆膜Wallstent支架的通畅率无显著差异。